Literature DB >> 11735229

RGSZ1 and Ret RGS: two of several splice variants from the gene RGS20.

S A Barker1, J Wang, D A Sierra, E M Ross.   

Abstract

RGSZ1 and Ret RGS, members of the regulator of G-protein signaling (RGS) family, are GTPase-activating proteins (GAPs) with high selectivity for G alpha(z). We show here that RGSZ1 and Ret RGSZ1 are products of two of several splice variants of one gene, RGS20. RGS20 spans approximately 107 kb and contains at least seven exons. Five exons account for RGSZ1, including a single exon distinct to RGSZ1 that encodes a newly identified amino-terminal region. The previously described open reading frame (ORF) and 3' untranslated region are encoded by four downstream exons that also encode about half of Ret RGS. The 5' end of the RGSZ1 ORF contains several in-frame ATG codons (3-5 depending on the species), and multiple translational start sites may help explain the molecular weight heterogeneity of purified bovine brain RGSZ. Ret RGS replaces the 24 N-terminal amino acid residues of RGSZ1 with a large, N-terminal region that initially distinguished the bovine Ret RGS from human and mouse RGSZ1. This N-terminal domain is encoded by two distinct 5' exons that are variably combined with the four downstream exons shared with RGSZ1 to produce at least six mRNAs. They encode proteins with N termini that vary in size, hydrophobicity, and the presence of a cysteine string. At least two mRNAs that include the exon that encodes the N-terminal region unique to RGSZ1 were found in brain and a few other tissues, but not retina. RGS20 thus can account for multiple G(z)-selective GAPs in different tissues.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11735229     DOI: 10.1006/geno.2001.6659

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  11 in total

Review 1.  Regulator of G Protein Signaling 17 as a Negative Modulator of GPCR Signaling in Multiple Human Cancers.

Authors:  Michael P Hayes; David L Roman
Journal:  AAPS J       Date:  2016-02-29       Impact factor: 4.009

Review 2.  Effector antagonism by the regulators of G protein signalling (RGS) proteins causes desensitization of mu-opioid receptors in the CNS.

Authors:  Javier Garzón; María Rodríguez-Muñoz; Elena de la Torre-Madrid; Pilar Sánchez-Blázquez
Journal:  Psychopharmacology (Berl)       Date:  2005-04-14       Impact factor: 4.530

Review 3.  Genetic Analysis of Rare Human Variants of Regulators of G Protein Signaling Proteins and Their Role in Human Physiology and Disease.

Authors:  Katherine E Squires; Carolina Montañez-Miranda; Rushika R Pandya; Matthew P Torres; John R Hepler
Journal:  Pharmacol Rev       Date:  2018-07       Impact factor: 25.468

4.  Suppression of RGSz1 function optimizes the actions of opioid analgesics by mechanisms that involve the Wnt/β-catenin pathway.

Authors:  Sevasti Gaspari; Immanuel Purushothaman; Valeria Cogliani; Farhana Sakloth; Rachael L Neve; David Howland; Robert H Ring; Elliott M Ross; Li Shen; Venetia Zachariou
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-12       Impact factor: 11.205

5.  Estradiol induces partial desensitization of serotonin 1A receptor signaling in the paraventricular nucleus of the hypothalamus and alters expression and interaction of RGSZ1 and Gαz.

Authors:  R D Creech; Q Li; G A Carrasco; L D Van de Kar; N A Muma
Journal:  Neuropharmacology       Date:  2012-01-10       Impact factor: 5.250

6.  RGS2 is a feedback inhibitor of melatonin production in the pineal gland.

Authors:  Masahiro Matsuo; Steven L Coon; David C Klein
Journal:  FEBS Lett       Date:  2013-03-21       Impact factor: 4.124

7.  Galphao/i-stimulated proteosomal degradation of RGS20: a mechanism for temporal integration of Gs and Gi pathways.

Authors:  Mario Pagano; J Dedrick Jordan; Susana R Neves; Tracy Nguyen; Ravi Iyengar
Journal:  Cell Signal       Date:  2008-02-19       Impact factor: 4.315

8.  RGS17: an emerging therapeutic target for lung and prostate cancers.

Authors:  Christopher R Bodle; Duncan I Mackie; David L Roman
Journal:  Future Med Chem       Date:  2013-06       Impact factor: 3.808

9.  A novel methyl-binding domain protein enrichment method for identifying genome-wide tissue-specific DNA methylation from nanogram DNA samples.

Authors:  Verity F Oliver; Jun Wan; Saurabh Agarwal; Donald J Zack; Jiang Qian; Shannath L Merbs
Journal:  Epigenetics Chromatin       Date:  2013-06-07       Impact factor: 4.954

10.  Promotion of G alpha i3 subunit down-regulation by GIPN, a putative E3 ubiquitin ligase that interacts with RGS-GAIP.

Authors:  Thierry Fischer; Luc De Vries; Timo Meerloo; Marilyn Gist Farquhar
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-25       Impact factor: 12.779

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.